Astec LifeSciences Limited (ASTEC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.036x

Based on the latest financial reports, Astec LifeSciences Limited (ASTEC) has a cash flow conversion efficiency ratio of -0.036x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-83.99 Million ≈ $-908.28K USD) by net assets (Rs2.35 Billion ≈ $25.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ASTEC equity financing ratio to measure how much of total assets are equity-financed.

Astec LifeSciences Limited - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Astec LifeSciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Astec LifeSciences Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Astec LifeSciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Astec LifeSciences Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Leclanche SA SW:LECN	0.518x
Assertio Therapeutics Inc NASDAQ:ASRT	0.113x
Tonix Pharmaceuticals Holding Corp NASDAQ:TNXP	-0.162x
Jarllytec Co Ltd TWO:3548	0.017x
USBC, Inc. NYSE MKT:USBC	-0.057x
Dune Acquisition Corporation II Class A Ordinary Shares NASDAQ:IPOD	0.000x
KOLIBRI GLOBAL ENERGY INC F:B120	0.061x
KG Eco Technology Services Co. Ltd KQ:151860	0.010x

Annual Cash Flow Conversion Efficiency for Astec LifeSciences Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Astec LifeSciences Limited from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Astec LifeSciences Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.35 Billion ≈ $25.42 Million	Rs-83.99 Million ≈ $-908.28K	-0.036x	-229.20%
2024-03-31	Rs3.70 Billion ≈ $39.96 Million	Rs102.21 Million ≈ $1.11 Million	0.028x	-84.46%
2023-03-31	Rs4.20 Billion ≈ $45.37 Million	Rs746.56 Million ≈ $8.07 Million	0.178x	+199.02%
2022-03-31	Rs3.97 Billion ≈ $42.90 Million	Rs236.04 Million ≈ $2.55 Million	0.060x	+325.51%
2021-03-31	Rs3.09 Billion ≈ $33.45 Million	Rs-81.62 Million ≈ $-882.72K	-0.026x	-103.87%
2020-03-31	Rs2.47 Billion ≈ $26.70 Million	Rs1.68 Billion ≈ $18.22 Million	0.682x	+805.15%
2019-03-31	Rs2.03 Billion ≈ $21.93 Million	Rs152.85 Million ≈ $1.65 Million	0.075x	-80.20%
2018-03-31	Rs1.70 Billion ≈ $18.38 Million	Rs646.75 Million ≈ $6.99 Million	0.381x	+173.44%
2017-03-31	Rs1.38 Billion ≈ $14.94 Million	Rs192.32 Million ≈ $2.08 Million	0.139x	+401.11%
2016-03-31	Rs1.17 Billion ≈ $12.65 Million	Rs-54.05 Million ≈ $-584.56K	-0.046x	-137.74%
2015-03-31	Rs1.35 Billion ≈ $14.64 Million	Rs165.82 Million ≈ $1.79 Million	0.122x	-21.96%
2014-03-31	Rs1.14 Billion ≈ $12.28 Million	Rs178.19 Million ≈ $1.93 Million	0.157x	+1.12%
2013-03-31	Rs1.06 Billion ≈ $11.45 Million	Rs164.31 Million ≈ $1.78 Million	0.155x	+77.15%
2012-03-31	Rs987.06 Million ≈ $10.67 Million	Rs86.48 Million ≈ $935.23K	0.088x	-48.14%
2011-03-31	Rs970.25 Million ≈ $10.49 Million	Rs163.91 Million ≈ $1.77 Million	0.169x	+50.01%
2010-03-31	Rs931.08 Million ≈ $10.07 Million	Rs104.85 Million ≈ $1.13 Million	0.113x	+252.98%
2009-03-31	Rs325.25 Million ≈ $3.52 Million	Rs-23.94 Million ≈ $-258.93K	-0.074x	-109.22%
2008-03-31	Rs229.75 Million ≈ $2.48 Million	Rs183.53 Million ≈ $1.98 Million	0.799x	--

About Astec LifeSciences Limited

NSE:ASTEC India Agricultural Inputs

Market Cap

$151.40 Million

Rs14.00 Billion INR

Market Cap Rank

#17573 Global

#936 in India

Share Price

Rs628.30

Change (1 day)

-4.13%

52-Week Range

Rs521.85 - Rs918.75

All Time High

Rs2248.18